Dr. Jonathan E. Howard, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Southern California Keck School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 49
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: University of Southern California Keck School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NY license 237565 -
Student in an Organized Health Care Education/Training Program
NY license 237565
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
- Bellevue Hospital Center New York, NY
Medical groups
- New York University (6,134 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 49
- Services billed
- 79
- Patients’ average age
- 62
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 73 | 51 |
| Established patient office or other outpatient visit, 30-39 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Dalfampridine Er (dalfampridine) | 143 |
| Gabapentin Other prescribers in New York, NY | 119 |
| Baclofen Other prescribers in New York, NY | 104 |
| Amitriptyline Hcl Other prescribers in New York, NY | 73 |
| Duloxetine Hcl Other prescribers in New York, NY | 73 |
| Bupropion Xl (bupropion hcl) Other prescribers in New York, NY | 69 |
| Clonazepam Other prescribers in New York, NY | 53 |
| Carbamazepine Er (carbamazepine) Other prescribers in New York, NY | 38 |
| Tecfidera (dimethyl fumarate) | 37 |
| Tramadol Hcl Other prescribers in New York, NY | 35 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 7 companies reported 17 payments worth $417 in total to this clinician.
| Celgene Corporation | $103 |
|---|---|
| Alexion Pharmaceuticals, Inc. | $91.69 |
| Tg Therapeutics, Inc. | $75.05 |
| Cycle Pharmaceuticals Inc | $46.53 |
| Biogen, Inc. | $45.53 |
| Novartis Pharmaceuticals Corporation | $34.18 |
| Amgen Inc. | $20.97 |
| Food and Beverage | $417 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $141,413 in research payments for these studies, mostly to the institutions running them.
- Understanding mRNA vaccine response in individuals with Multiple Sclerosis on Tysabri and Vumerity
Biogen, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.